Jason Cohen (@memorydoc) 's Twitter Profile
Jason Cohen

@memorydoc

Neurologist, dementia specialist, New Yorker, dad. At 🦋. Puns welcome. @NeuroMonteEinst. @MontefioreNYC. All opinions my own. No medical advice. He/him.

ID: 1404622453071036419

calendar_today15-06-2021 02:13:16

4,4K Tweet

1,1K Followers

874 Following

Craig Spencer MD MPH (@craig_a_spencer) 's Twitter Profile Photo

How much do you know about food and drug safety? Where did our current regulations come from? And what were some of the greatest scandals that forced change? We covered everything from swill milk, patent medicines, and thalidomide in our class today. Here's what we covered đź§µ

How much do you know about food and drug safety?

Where did our current regulations come from?

And what were some of the greatest scandals that forced change?

We covered everything from swill milk, patent medicines, and thalidomide in our class today.

Here's what we covered đź§µ
Senator Andrew Gounardes (@sen_gounardes) 's Twitter Profile Photo

Where do I file my refund request for the thousands of dollars in NJ Turnpike tolls I’ve paid over the years to support NJ’s travel infrastructure? It’s unconscionable that NYers should have to pay to use NJ’s roads.

Eric Widera, MD (@ewidera) 's Twitter Profile Photo

From pre-diabetes to Alzheimer’s disease in the cognitively normal, there is an ongoing push to label healthy individuals as sick. Who benefits from this and who is harmed? One of my favorite med journalism articles of 2024 dives into the debate. 🧵 1/4 latimes.com/science/story/…

Eric Widera, MD (@ewidera) 's Twitter Profile Photo

Medicine focuses a lot on the question “will this help my patient” but not on the question “when will it help my patient.” The latter becomes important as we age. We’ve developed a “time-to-benefit” tool on eprognosis.ucsf.edu to help answer this question. #FOAMed #meded

Medicine focuses a lot on the question “will this help my patient” but not on the question “when will it help my patient.” The latter becomes important as we age. We’ve developed a “time-to-benefit” tool on eprognosis.ucsf.edu to help answer this question. 
#FOAMed #meded
Jason Cohen (@memorydoc) 's Twitter Profile Photo

I wouldn't start infusing everyone w iron or even supplementing w pills, but I do expect Fe homeostasis to be a more common target for dementia research in the years ahead nature.com/articles/s4138…

Alzforum (@alzforum) 's Twitter Profile Photo

At #CTAD24, biomarker data suggest black and Hispanic people are less likely to have amyloid. Some suspect that comorbidities might contribute to cognitive decline. ow.ly/F0HG50Ubb22

Victor Del Bene (@victor_delbene) 's Twitter Profile Photo

New paper! Meta-analysis on cognitive intra-individual variability (IIV) in APOE-E4 carriers, MCI, and Alzheimer's dementia. link.springer.com/article/10.100…

Nico Franzmeier (@nfranzme) 's Twitter Profile Photo

New paper alert: A two-cutoff CSF Aβ42/40 approach improves Aβ detection in real world clinical settings. CSF Aβ42/40≥7.1 rules out amyloid, while ratios~5.5–7.1 benefit from Aβ PET. Key for Lecanemab stratification. #Alzheimers #Biomarkers 📄 doi.org/10.1002/dad2.7…

Jason Cohen (@memorydoc) 's Twitter Profile Photo

These woods are dark and filled with trolls. I'm going to explore bluer places with clearer skies. Same handle 🦋

Lea Alhilali, MD (@teachplaygrub) 's Twitter Profile Photo

1/Controversy in radiology can get tense! The Mt Fuji sign for tension pnemocephalus is under scrutiny. When should you call it? A thread about imaging this important neurosurgery complication

1/Controversy in radiology can get tense!

The Mt Fuji sign for tension pnemocephalus is under scrutiny. When should you call it?

A thread about imaging this important neurosurgery complication
Matthew Schrag (@schrag_matthew) 's Twitter Profile Photo

Does this look right to you? Let me take you down a rabbit hole to illustrate how a network of interlacing problems in Alzheimer’s disease research ethics impacts our progress on this disease.

Does this look right to you?
Let me take you down a rabbit hole to illustrate how a network of interlacing problems in Alzheimer’s disease research ethics impacts our progress on this disease.